Mega-Deals, Explained: The 2026 Field Guide
What mega-deals covers, why it matters in 2026, and the numbers decision-makers should know.
If one theme defines digital health in 2026, it is the maturing of mega-deals. The $100M+ rounds absorbing nearly half of digital health capital. This explainer sets out what the category actually covers, why it has moved to the center of funding & m&a strategy, and the numbers every decision-maker should have at hand.
What it covers
The $100M+ rounds absorbing nearly half of digital health capital. In practice, that spans the vendors building the technology, the health systems and payers deploying it, and the regulators writing the rules around it. The category sits inside our broader Funding & M&A coverage, and its daily developments stream into the live Mega-Deals feed.
Why it matters in 2026
Consider the current numbers: uS digital health startups raised $7.4 billion across 244 deals in H1 2026, with 45% of capital in $100M+ megadeals (our analysis).
Meanwhile, 115 acquisitions made the first half the busiest M&A run since 2021.
Meanwhile, talkiatry's $210 million Series D anchored mental health's seventh straight year atop the clinical funding charts (our coverage).
What to watch next
Three signals will tell you where mega-deals goes from here: the reimbursement decisions now moving through CMS and commercial payers, the consolidation pattern as larger platforms absorb point solutions, and the evidence base - peer-reviewed results increasingly separate durable categories from demo-ware.
The bottom line
As with every wave before it, the technology is necessary but not sufficient - workflow, incentives, and trust decide the outcome. For the latest developments, follow our continuously updated Mega-Deals topic page.